1090 related articles for article (PubMed ID: 29311644)
21. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.
Liu B; Ye D; Yang H; Song J; Sun X; Mao Y; He Z
Front Immunol; 2022; 13():921546. PubMed ID: 35860271
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory bowel disease biomarkers of human gut microbiota selected via different feature selection methods.
Bakir-Gungor B; Hacılar H; Jabeer A; Nalbantoglu OU; Aran O; Yousef M
PeerJ; 2022; 10():e13205. PubMed ID: 35497193
[TBL] [Abstract][Full Text] [Related]
23. The Gut Microbiota in Collagenous Colitis Shares Characteristics With Inflammatory Bowel Disease-Associated Dysbiosis.
Carstens A; Dicksved J; Nelson R; Lindqvist M; Andreasson A; Bohr J; Tysk C; Talley NJ; Agréus L; Engstrand L; Halfvarson J
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00065. PubMed ID: 31343467
[TBL] [Abstract][Full Text] [Related]
24. Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity.
Mills RH; Dulai PS; Vázquez-Baeza Y; Sauceda C; Daniel N; Gerner RR; Batachari LE; Malfavon M; Zhu Q; Weldon K; Humphrey G; Carrillo-Terrazas M; Goldasich LD; Bryant M; Raffatellu M; Quinn RA; Gewirtz AT; Chassaing B; Chu H; Sandborn WJ; Dorrestein PC; Knight R; Gonzalez DJ
Nat Microbiol; 2022 Feb; 7(2):262-276. PubMed ID: 35087228
[TBL] [Abstract][Full Text] [Related]
25. Microbial Dynamics in Newly Diagnosed and Treatment Naïve IBD Patients in the Mediterranean.
Rausch P; Ellul S; Pisani A; Bang C; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
Inflamm Bowel Dis; 2023 Jul; 29(7):1118-1132. PubMed ID: 36735955
[TBL] [Abstract][Full Text] [Related]
26. Gut microbial co-abundance networks show specificity in inflammatory bowel disease and obesity.
Chen L; Collij V; Jaeger M; van den Munckhof ICL; Vich Vila A; Kurilshikov A; Gacesa R; Sinha T; Oosting M; Joosten LAB; Rutten JHW; Riksen NP; Xavier RJ; Kuipers F; Wijmenga C; Zhernakova A; Netea MG; Weersma RK; Fu J
Nat Commun; 2020 Aug; 11(1):4018. PubMed ID: 32782301
[TBL] [Abstract][Full Text] [Related]
27. Microbial Signatures and Innate Immune Gene Expression in Lamina Propria Phagocytes of Inflammatory Bowel Disease Patients.
Dheer R; Davies JM; Quintero MA; Damas OM; Deshpande AR; Kerman DH; Sawyer WP; Pignac-Kobinger J; Ban Y; Fernandez I; Burgueno JF; Phillips MC; Abreu MT
Cell Mol Gastroenterol Hepatol; 2020; 9(3):387-402. PubMed ID: 31740421
[TBL] [Abstract][Full Text] [Related]
28. Whole-Virome Analysis Sheds Light on Viral Dark Matter in Inflammatory Bowel Disease.
Clooney AG; Sutton TDS; Shkoporov AN; Holohan RK; Daly KM; O'Regan O; Ryan FJ; Draper LA; Plevy SE; Ross RP; Hill C
Cell Host Microbe; 2019 Dec; 26(6):764-778.e5. PubMed ID: 31757768
[TBL] [Abstract][Full Text] [Related]
29. Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review.
Pittayanon R; Lau JT; Leontiadis GI; Tse F; Yuan Y; Surette M; Moayyedi P
Gastroenterology; 2020 Mar; 158(4):930-946.e1. PubMed ID: 31812509
[TBL] [Abstract][Full Text] [Related]
30. Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy.
Schierova D; Roubalova R; Kolar M; Stehlikova Z; Rob F; Jackova Z; Coufal S; Thon T; Mihula M; Modrak M; Kverka M; Bajer L; Kostovcikova K; Drastich P; Hercogova J; Novakova M; Vasatko M; Lukas M; Tlaskalova-Hogenova H; Jiraskova Zakostelska Z
Cells; 2021 Nov; 10(11):. PubMed ID: 34831411
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis defines predominant shared microbial responses in various diseases and a specific inflammatory bowel disease signal.
Abbas-Egbariya H; Haberman Y; Braun T; Hadar R; Denson L; Gal-Mor O; Amir A
Genome Biol; 2022 Feb; 23(1):61. PubMed ID: 35197084
[TBL] [Abstract][Full Text] [Related]
32. Microbiota as Therapeutic Targets.
Xavier RJ
Dig Dis; 2016; 34(5):558-65. PubMed ID: 27331403
[TBL] [Abstract][Full Text] [Related]
33. Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria.
Wang W; Jovel J; Halloran B; Wine E; Patterson J; Ford G; OʼKeefe S; Meng B; Song D; Zhang Y; Tian Z; Wasilenko ST; Rahbari M; Reza S; Mitchell T; Jordan T; Carpenter E; Madsen K; Fedorak R; Dielemann LA; Ka-Shu Wong G; Mason AL
Inflamm Bowel Dis; 2015 Jun; 21(6):1419-27. PubMed ID: 25939040
[TBL] [Abstract][Full Text] [Related]
34. Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease.
Vrakas S; Mountzouris KC; Michalopoulos G; Karamanolis G; Papatheodoridis G; Tzathas C; Gazouli M
PLoS One; 2017; 12(1):e0170034. PubMed ID: 28099495
[TBL] [Abstract][Full Text] [Related]
35. Dysregulated Immunity to Clostridioides difficile in IBD Patients Without a History of Recognized Infection.
Cook L; Wong MQ; Rees WD; Schick A; Lisko DJ; Lunken GR; Wang X; Peters H; Oliveira L; Lau T; Mah R; Bressler B; Levings MK; Steiner TS
Inflamm Bowel Dis; 2024 May; 30(5):820-828. PubMed ID: 37874904
[TBL] [Abstract][Full Text] [Related]
36. Microbiota and IBD: Current knowledge and future perspectives.
Foppa C; Rizkala T; Repici A; Hassan C; Spinelli A
Dig Liver Dis; 2024 Jun; 56(6):911-922. PubMed ID: 38008696
[TBL] [Abstract][Full Text] [Related]
37. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
Kabeerdoss J; Jayakanthan P; Pugazhendhi S; Ramakrishna BS
Indian J Med Res; 2015 Jul; 142(1):23-32. PubMed ID: 26261163
[TBL] [Abstract][Full Text] [Related]
38. Microbiome and metabolome in inflammatory bowel disease.
Upadhyay KG; Desai DC; Ashavaid TF; Dherai AJ
J Gastroenterol Hepatol; 2023 Jan; 38(1):34-43. PubMed ID: 36287112
[TBL] [Abstract][Full Text] [Related]
39. Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease.
Weng YJ; Gan HY; Li X; Huang Y; Li ZC; Deng HM; Chen SZ; Zhou Y; Wang LS; Han YP; Tan YF; Song YJ; Du ZM; Liu YY; Wang Y; Qin N; Bai Y; Yang RF; Bi YJ; Zhi FC
J Dig Dis; 2019 Sep; 20(9):447-459. PubMed ID: 31240835
[TBL] [Abstract][Full Text] [Related]
40. Development of Inflammatory Bowel Disease Is Linked to a Longitudinal Restructuring of the Gut Metagenome in Mice.
Sharpton T; Lyalina S; Luong J; Pham J; Deal EM; Armour C; Gaulke C; Sanjabi S; Pollard KS
mSystems; 2017; 2(5):. PubMed ID: 28904997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
